Drugging the Undruggable Clinical Oncology News
In his talk at NCRI, Dr. Fang discussed Genentech's preliminary success determining the druggability of Ras using nuclear magnetic resonance (NMR)-based fragment screening. â??We analyzed the binding of molecules to the Ras protein itself, not yet asking ...
Drugging the Undruggable - Clinical Oncology News More...